A
0.290
-0.03 (-9.38%)
| Penutupan Terdahulu | 0.320 |
| Buka | 0.295 |
| Jumlah Dagangan | 10,495 |
| Purata Dagangan (3B) | 29,933 |
| Modal Pasaran | 23,174,916 |
| Harga / Buku (P/B) | 3.42 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Aug 2024 - 28 Aug 2024 |
| EPS Cair (TTM) | -0.180 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 5.65% |
| Nisbah Semasa (MRQ) | 7.34 |
| Aliran Tunai Operasi (OCF TTM) | -15.41 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.84 M |
| Pulangan Atas Aset (ROA TTM) | -34.45% |
| Pulangan Atas Ekuiti (ROE TTM) | -59.12% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (AU) | Bercampur | Bercampur |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | ARTRYA FPO [AYA] | - | - |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.13 |
|
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 38.94% |
| % Dimiliki oleh Institusi | 4.66% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |